Search

everythinglearnresearchcommunity

for

Search:↓

A3B5 can reduce skin pigmentation and slow melanoma growth.

A rare skin cancer caused hair loss and spread, needing multiple treatments.

Melanocyte pathology requires keratinocyte hyperplasia and regulation dysfunction.

Peanut agglutinin staining helps differentiate malignant melanoma from nevocellular nevus.

Targeted therapies for advanced skin cancer often cause hair and nail problems, which need managing to avoid changing the treatment dose.

Lentiginous melanoma is most common on the face, especially the nose, cheek, and pre-auricular areas, with men more likely to have it on the scalp, ears, upper back, and trapezius, and women on the cheek and anterior arm. Sun damage is a key factor in its formation.

MITF+ melanoma patients are more likely to have multiple melanomas and unique skin patterns.

Dermoscopy greatly improves melanoma diagnosis and reduces unneeded surgeries.

Non-melanoma skin cancer in darker-skinned people can be misdiagnosed, so doctors need to be more aware to diagnose it correctly and early.

Melanoma occurs more on the left side of the body, unlike other skin cancers.

Targeting multiple pathways and understanding genetic mutations are crucial for effective melanoma therapy.

People with myotonic dystrophy type 1 have a higher chance of getting skin tumors, including melanoma.

Two women were diagnosed with a rare melanoma that looked like hair loss but was actually a type of skin cancer.

A person had two different benign skin tumors, a trichoadenoma and melanocytic naevi, at the same time but in different places on the face.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Scalp melanomas are more dangerous and likely to recur or cause death than other head and neck melanomas.

Podiatrists need more training to detect foot melanoma early.

Skin side effects from melanoma immunotherapy are common and may indicate better survival.

Early subungual melanoma might be treated with less aggressive surgery because it invades the skin under the nail more slowly.

Finasteride and dutasteride might lower melanoma risk.

Darker skin provides more protection against UV damage and cancer.

Where melanoma is on the body affects survival chances; melanomas on the back of the head are worse, while those on thighs and arms are less severe, and more sun exposure might improve survival.

Nestin helps identify certain melanoma cells in nodular melanoma.

Finasteride and dutasteride may lower melanoma risk, with teenage acne possibly indicating higher risk.

Living near more dermatologists and using certain cancer screening tests lowers the chance of being diagnosed with advanced skin cancer.

Melanoma thickness at diagnosis is linked to access to dermatologists and preventive services, not to socioeconomic status.

Nivolumab treatment led to hair regrowth in a man with metastatic melanoma and alopecia areata.

Uveal melanoma is hard to treat when it spreads, but a new drug, tebentafusp, helps patients live longer.

Scalp melanoma, a deadly skin cancer, is often found late due to its hard-to-see location, especially in older men. Early detection, possible treatments, and the role of hairdressers in spotting it early are discussed. More research is needed to improve detection and treatment.